LCP-tacrolimus QD + MMF QD then MMF QD clinical trials

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

This study looks at how people who have had liver transplants take their medicines. We want to see if taking a single daily dose of anti-rejection medicines works as well as taking them twice a day. This might make it easier for patients and improve their quality of life.